| Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies YT Png, N Vinanica, T Kamiya, N Shimasaki, E Coustan-Smith, ... Blood advances 1 (25), 2348-2360, 2017 | 171 | 2017 |
| A novel method to generate T-cell receptor–deficient chimeric antigen receptor T cells T Kamiya, D Wong, YT Png, D Campana Blood advances 2 (5), 517-528, 2018 | 80 | 2018 |
| Human MAIT cell cytolytic effector proteins synergize to overcome carbapenem resistance in Escherichia coli C Boulouis, WR Sia, MY Gulam, JQM Teo, YT Png, TK Phan, JYW Mak, ... PLoS biology 18 (6), e3000644, 2020 | 58 | 2020 |
| The role of NK cells in EBV infection and EBV-associated NPC YT Png, AZY Yang, MY Lee, MJM Chua, CM Lim Viruses 13 (2), 300, 2021 | 36 | 2021 |
| Specific stimulation of T lymphocytes with erythropoietin for adoptive immunotherapy N Vinanica, A Yong, D Wong, YT Png, SV Seow, M Imamura, D Campana Blood, The Journal of the American Society of Hematology 135 (9), 668-679, 2020 | 13 | 2020 |
| Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies YT Png, N Vinanica, T Kamiya, D Campana US Patent 10,550,183, 2020 | 13 | 2020 |
| Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies YT Png, N Vinanica, T Kamiya, D Campana US Patent 11,440,958, 2022 | 4 | 2022 |
| Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies YT Png, N Vinanica, T Kamiya, D Campana US Patent 11,945,865, 2024 | 1 | 2024 |
| Blockade of cd7 expression and chimeric antigen receptors for immunotherapy of t-cell malignancies D Campana, N VINANICA, T KAMAYA, YT PNG | 1 | 2018 |
| Blockade of CD2 surface expression and expression of chimeric antigen receptors for immunotherapy of T-cell malignancies D Campana, N Vinanica, YT Png, T Kamiya US Patent 12,129,485, 2024 | | 2024 |
| Blockade of cd7 expression and chimeric antigen receptors for immunotherapy of t-cell malignancies YT Png, N Vinanica, T Kamiya, D Campana US Patent App. 18/583,551, 2024 | | 2024 |
| P-16 Evaluation of two ratios predicting natural killer cell function in nasopharyngeal and other head and neck cancers patients leading towards better prognosis BM Cher, AKF Liou, QH Poh, YT Png, AZY Yang, CM Lim Oral Oncology 118, 7, 2021 | | 2021 |
| Abstract PO075: Re-invigorating tumor infiltrating T lymphocytes against EBV positive nasopharyngeal cancer Y Png, A Zhi-Yi Yang, L Soo-Yee Tan, SV Seow, SL Asidharan, J Mong, ... Cancer Immunology Research 9 (2_Supplement), PO075-PO075, 2021 | | 2021 |
| US 10,550,183 B2-Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies| RPX Insight YT Png, N Vinanica, T Kamiya, D Campana | | 2020 |
